low-dose azacitidine and venetoclax as maintenance therapy in patients with aml
Published 1 year ago • 1.1K plays • Length 2:27Download video MP4
Download video MP3
Similar videos
-
2:37
maintenance venetoclax and 5-azacytidine in patients with aml
-
4:13
ven-a-qui: low-dose cytarabine or azacitidine venetoclax and quizartinib in older patients with aml
-
2:19
cladribine ldac venetoclax alternated with azacitidine venetoclax in older patients with aml
-
1:46
tagraxofusp combined with azacitidine and venetoclax in the treatment of bpdcn and aml
-
5:36
venetoclax and azacitidine in mds patients
-
12:05
venetoclax combinations, safety and efficacy
-
4:52
apoptosis and venetoclax
-
7:46
updates in aml treatment and research from asco 2023
-
3:22
phase i/ii study of milademetan plus low-dose cytarabine with or without venetoclax in r/r aml
-
2:43
venetoclax azacitidine in unfit patients with aml
-
1:48
azacitidine and venetoclax maintenance post allosct in high-risk t-all
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
1:56
evaluating long-term survival in patients with aml who discontinued azacitidine-venetoclax
-
1:32
is venetoclax in combination with low-dose cytarabine a safe regimen for the treatment of aml?
-
2:17
outcomes of patients with monocytic aml treated with venetoclax & azacitidine
-
3:40
phase ii study of venetoclax and azacitidine vs induction chemotherapy in fit patients with aml
-
1:40
venetoclax and azacitidine in older patients with aml
-
3:09
bleximenib combined with venetoclax and azacitidine in r/r aml with kmt2a or npm1 alterations
-
3:03
venetoclax and 5-azacytidine for the treatment of mds and cmml
-
2:38
venetoclax in combination with low-dose cytarabine – a promising regimen for the treatment of aml
-
2:49
venetoclax and azacitidine for young patients with aml
-
1:24
omniverse: safety and tolerability of oral azacitidine plus venetoclax in patients with aml